ABEO
ABEONA THERAPEUTICS INC. · Healthcare · Market cap $257.9M
Insiders sold $1.1M net in the last 90 days ·5 sellers, 0 buyers· latest Form 4 filed Sep 30, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.6M
reported sales (SEC code S)
Unique Insiders
9
in the rolling window
Latest filing
Sep 30, 2026
Seshadri Vishwas
ABEONA THERAPEUTICS INC. (ABEO) has 47 SEC Form 4 filings (53 transaction rows) in the rolling window, disclosed by 9 distinct insiders. Most recent filing: Sep 30, 2026.
Inside the rolling window, 9 insiders at ABEONA THERAPEUTICS INC. reported no open-market purchases and 37 open-market sales totaling $3.6M. The most active filer is Chief Executive Officer Seshadri Vishwas with 7 filings. Insiders have net sold $2.2M over the trailing 6 months. The most recent open-market filing is a sale of 19,608 shares by Chief Executive Officer Seshadri Vishwas, dated Sep 29, 2026, worth $101K.
- Industry:Biotechnology
- CEO:Vishwas Seshadri
- Employees:226
- HQ:Cleveland, OH, US
- IPO:1980-09-19
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Executive Officer | Sale | 19,608 | $101K | Sep 30 | -14.1% | SEC ↗ | |
| Chief Financial Officer | Sale | 9,191 | $47K | Sep 30 | -14.1% | SEC ↗ | |
| SVP, Chief Legal Officer | Sale | 6,727 | $35K | Sep 30 | -14.1% | SEC ↗ | |
| Chief Commercial Officer | Sale | 4,902 | $25K | Sep 30 | -14.1% | SEC ↗ | |
Alvino MarkFirst in 3 months | Director | Sale | 15,000 | $88K | Sep 1 | -24.6% | SEC ↗ |
| Chief Financial Officer | Sale | 1,478 | $10K | Jul 22 | -29.8% | SEC ↗ | |
| Chief Financial Officer | Sale | 24,880 | $173K | Jul 9 | -36.7% | SEC ↗ | |
| Chief Executive Officer | Sale | 67,971 | $473K | Jul 9 | -36.7% | SEC ↗ | |
| SVP, Chief Legal Officer | Sale | 12,050 | $84K | Jul 9 | -36.7% | SEC ↗ | |
| Chief Commercial Officer | Sale | 12,606 | $88K | Jul 9 | -36.7% | SEC ↗ | |
Alland LeilaFirst in 5 months | Director | Sale | 11,000 | $65K | Jul 2 | — | SEC ↗ |
Silverstein Christine BerniFirst in 4 months | Director | Sale | 18,160 | $104K | Jun 15 | — | SEC ↗ |
O'Malley Brendan M.First in 5 months | SVP, Chief Legal Officer | Sale | 4,826 | $26K | Jun 10 | — | SEC ↗ |
O'Malley Brendan M.First in 5 months | SVP, Chief Legal Officer | Sale | 6,305 | $33K | Jun 10 | — | SEC ↗ |
| Chief Financial Officer | Sale | 10,271 | $56K | Jun 10 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 39,067 | $209K | Jun 10 | — | SEC ↗ | |
| Chief Commercial Officer | Sale | 4,170 | $23K | Jun 10 | — | SEC ↗ | |
| Chief Commercial Officer | Sale | 5,450 | $29K | Jun 10 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 24,428 | $133K | Jun 10 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 31,916 | $169K | Jun 10 | — | SEC ↗ | |
Alvino MarkFirst in 4 months | Director | Sale | 6,500 | $35K | May 22 | — | SEC ↗ |
| Director | Sale | 26,143 | $145K | May 15 | — | SEC ↗ | |
Vasanthavada MadhavFirst in 4 months | Chief Commercial Officer | Sale | 5,548 | $33K | May 11 | — | SEC ↗ |
| Chief Executive Officer | Sale | 29,985 | $131K | Mar 31 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 785 | $4K | Mar 16 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does ABEO have?
ABEONA THERAPEUTICS INC. (ABEO) has 47 SEC Form 4 filings (53 transaction rows) in the rolling 365-day window, disclosed by 9 distinct insiders. Most recent filing: Sep 30, 2026.
When was the most recent SEC Form 4 filing for ABEO?
The most recent Form 4 filing for ABEO on Tracefour is dated Sep 30, 2026.
Who is the most active insider at ABEO?
The most active SEC Form 4 filer at ABEO in the rolling window is Chief Executive Officer Seshadri Vishwas, with 7 filings.
What is the net insider flow at ABEO over the last 6 months?
Over the trailing 180 days, insiders at ABEO have net sold $2.2M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ABEO in the current window?
Inside the rolling window, insiders at ABEO bought $0 and sold $3.6M based on SEC Form 4 filings.
Can I get alerts for ABEO insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at ABEONA THERAPEUTICS INC. (ABEO). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
ABEONA THERAPEUTICS INC. is in the Healthcare sector.